Prof. Dr. YILMAZ ÇAPAN

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 68

1. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.

Tonbul H., Şahin A., Öztürk S. C., Ultav G., Tavukçuoğlu E., Akbaş S., et al.

Journal of drug targeting , cilt.32, sa.9, ss.1101-1110, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Development and In Vitro Evaluation of Quercetin Loaded Folic Acid Conjugated PLGA Nanoparticles for the Treatment of Breast Cancer

Çetiner K., Seko I., Ulutürk S., Gür B., Şahin A., Çapan Y.

ACTA FARMACEUTICA BONAERENSE , cilt.43, sa.10, ss.2177-2183, 2024 (SCI-Expanded)

3. Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin® Biosimilar Candidate and Its Innovator: A Comparative Study

Gurel B., Berksoz M., Capkin E., Parlar A., Pala M. C., Ozkan A., et al.

Pharmaceutics , cilt.14, sa.8, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

4. Preface

ÇAPAN Y., Sahin A., TONBUL H.

Drug Delivery with Targeted Nanoparticles: In Vitro and in Vivo Evaluation Methods , cilt.30, 2021 (SCI-Expanded)

5. Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier

Seko I., TONBUL H., Tavukcuoglu E., Sahin A., Akbas S., Yanik H., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.66, 2021 (SCI-Expanded)

6. Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells

TONBUL H., Sahin A., Tavukcuoglu E., Ultav G., AKBAŞ S., AKTAŞ Y., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.63, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

7. Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis

Yuce M., Sert F., Torabfam M., Parlar A., Gurel B., Cakir N., et al.

ANALYTICA CHIMICA ACTA , cilt.1152, 2021 (SCI-Expanded)

8. pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML)

Ultav G., TONBUL H., Tavukcuoglu E., ÖZTÜRK S., Akbas S., Sahin A., et al.

Journal of Nanoparticle Research , cilt.24, sa.2, 2021 (SCI-Expanded)

9. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration

Caban-Toktas S., Sahin A., Lule S., Esendagli G., Vural I., Karlı Oguz K., et al.

International Journal of Pharmaceutics , cilt.578, 2020 (SCI-Expanded)

10. Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer

Tonbul H., Sahin A., Tavukcuoglu E., ESENDAĞLI G., ÇAPAN Y.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.54, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

11. Preclinical evaluation of a biobetter candidate: Pharmacokinetics and pharmacodynamics of GX-G3 in healthy and neutropenia-induced rats

Kim Y. J., Ertan-Ahmed S., ÇAPAN Y., Yang S. I.

Drug Development Research , cilt.80, sa.6, ss.807-813, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

12. Nano-Based Carriers for Brain Drug Delivery

ÖZTÜRK ATAR K., Ozkan M. Y., EROĞLU H., ÇAPAN Y.

CHARACTERIZATION AND BIOLOGY OF NANOMATERIALS FOR DRUG DELIVERY: NANOSCIENCE AND NANOTECHNOLOGY IN DRUG DELIVERY , ss.563-586, 2019 (SCI-Expanded)

13. DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING HPLC METHOD FOR DIFLUCORTOLONE VALERATE AND ISOCONAZOLE NITRATE COMBINATION

Gundogdu S. O., Simsek F., Doganay A., Capan Y.

ACTA POLONIAE PHARMACEUTICA , cilt.76, sa.1, ss.49-58, 2019 (SCI-Expanded)

14. Nanopharmaceuticals as Drug-Delivery Systems: For, Against, and Current Applications

ÇALIŞ S., ÖZTÜRK ATAR K., ARSLAN F. N., EROĞLU H., ÇAPAN Y.

NANOCARRIERS FOR DRUG DELIVERY: NANOSCIENCE AND NANOTECHNOLOGY IN DRUG DELIVERY , ss.133-154, 2019 (SCI-Expanded)

15. Synthesis of Small-Sized Mesoporous Silica Nanoparticles by Experimental Design and Characterization for Further Drug Delivery

TONBUL H., Ultav G., AKBAŞ S., Sahin A., AKTAŞ Y., ÇAPAN Y.

LATIN AMERICAN JOURNAL OF PHARMACY , cilt.38, sa.11, ss.2204-2210, 2019 (SCI-Expanded)

16. Synthesis of small-sized mesoporous silica nanoparticles by experimental design and characterization for further drug delivery

Tonbul H., Ultav G., Akbaş S., Şahin A., Aktaş Y., Çapan Y.

Latin American Journal of Pharmacy , cilt.38, sa.11, ss.2204-2210, 2019 (SCI-Expanded)

17. Simultaneous Determination of Dexpanthenol, Lidocaine Hydrochloride, Mepyramine Maleate and their Related Substances by a RP-HPLC Method in Topical Dosage Forms

Doganay A., Koksel B., Gundogdu S., ÇAPAN Y.

Journal of chromatographic science , cilt.56, sa.10, ss.903-911, 2018 (SCI-Expanded)

18. Characterization of bevacizumab by dynamic light scattering while maintaining its native structure

Akbas S., Sahin A., ÇALIŞ S., Oncel H., ÇAPAN Y.

PHARMAZIE , cilt.73, sa.7, ss.369-374, 2018 (SCI-Expanded)

19. Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles

Kozlu S., Sahin A., Ultav G., Yerlikaya F., ÇALIŞ S., ÇAPAN Y.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.45, ss.213-219, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

20. Preparation and Characterization of Biocompatible Chitosan Nanoparticles for Targeted Brain Delivery of Peptides

Yemisci M., Caban S., Fernandez-Megia E., ÇAPAN Y., Couvreur P., DALKARA T.

NEUROTROPHIC FACTORS: METHODS AND PROTOCOLS, 2ND EDITION , cilt.1727, ss.443-454, 2018 (SCI-Expanded)

21. Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC)

Kozlu S., ŞAHİN A., ÇALIŞ S., ÇAPAN Y.

PHARMAZIE , cilt.72, sa.10, ss.568-570, 2017 (SCI-Expanded)

22. DEVELOPMENT AND VALIDATION OF HPLC ANALYTICAL METHODS USED FOR DETERMINATION OF ASSAY, CONTENT UNIFORMITY AND DISSOLUTION OF IMMEDIATE RELEASE CANDESARTAN CILEXETIL 32 MG TABLETS

YÜCE M., ÇAPAN Y.

ACTA POLONIAE PHARMACEUTICA , cilt.74, sa.2, ss.357-367, 2017 (SCI-Expanded)

23. Evaluation of brain-targeted chitosan nanoparticles through blood-brain barrier cerebral microvessel endothelial cells

Sahin A., Yoyen-Ermis D., Caban-Toktas S., Horzum U., AKTAŞ Y., Couvreur P., et al.

JOURNAL OF MICROENCAPSULATION , cilt.34, sa.7, ss.659-666, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

24. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery

ŞAHİN A., ESENDAĞLI G., YERLİKAYA F., Caban-Toktas S., Yoyen-Ermis D., HORZUM U., et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , cilt.45, sa.8, ss.1657-1664, 2017 (SCI-Expanded)

25. Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles

Sahin A., Spiroux F., Guedon I., Arslan F., Sarcan E., Ozkan T., et al.

Pharmazie , cilt.72, sa.9, ss.525-528, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

26. Preformulation of Immediate Release Candesartan Cilexetil Tablets Using Full Factorial Experimental Design

YÜCE M., Guven O., KARAHAN S., Saracbasi O., ÇAPAN Y.

LATIN AMERICAN JOURNAL OF PHARMACY , cilt.35, sa.5, ss.921-930, 2016 (SCI-Expanded)

27. Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection

Yemisci M., Caban S., Gursoy-Ozdemir Y., Lule S., NOVOA-CARBALLAL R., RIGUERA R., et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM , cilt.35, sa.3, ss.469-475, 2015 (SCI-Expanded)

28. Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury

Gaudin A., YEMİŞCİ ÖZKAN M., EROĞLU H., Lepetre-Mouelhi S., Turkoglu O. F., DEMİR B. N., et al.

NATURE NANOTECHNOLOGY , cilt.9, sa.12, ss.1054-1062, 2014 (SCI-Expanded)

29. An aquaporin 4 antisense oligonucleotide loaded, brain targeted nanoparticulate system design

KOZLU S., CABAN S., YERLIKAYA F., FERNANDEZ-MEGIA E., NOVOA-CARBALLAL R., RIGUERA R., et al.

PHARMAZIE , cilt.69, sa.5, ss.340-345, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

30. Comparative in vitro studies on PBN loaded nanoparticles prepared by biodegradable chitosan, PLGA polymers and their PEGylated block copolymers

Ozturk K., FERNANDEZ-MEGIA E., NOVOA-CARBALLAL R., RIGUERA R., Yemisci M., GURSOY-OZDEMIR Y., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.24, sa.2, ss.148-152, 2014 (SCI-Expanded)

31. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

Yerlikaya F., Ozgen A., VURAL İ., Guven O., Karaagaoglu E., Khan M. A., et al.

JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.102, sa.10, ss.3748-3761, 2013 (SCI-Expanded)

32. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression

OLMEZ S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.

PHARMAZIE , cilt.68, sa.2, ss.110-116, 2013 (SCI-Expanded)

33. TRANSPORT OF A CASPASE INHIBITOR ACROSS THE BLOOD BRAIN BARRIER BY CHITOSAN NANOPARTICLES

YEMISCI M., GURSOY-OZDEMIR Y., CABAN S., BODUR E., ÇAPAN Y., DALKARA T.

NANOMEDICINE: CANCER, DIABETES, AND CARDIOVASCULAR, CENTRAL NERVOUS SYSTEM, PULMONARY AND INFLAMMATORY DISEASES , cilt.508, ss.253-269, 2012 (SCI-Expanded)

34. CHARACTERIZATION, CELL PROLIFERATION AND CYTOTOXICITY EVALUATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR LOADED POLY (LACTIC-CO-GLYCOLIC ACID) MICROSPHERES

KERİMOĞLU O., ALARÇİN E., Turkoglu M., Dortunc B., Karagoz H., Ulkur E., et al.

NOBEL MEDICUS , cilt.8, sa.1, ss.77-82, 2012 (SCI-Expanded)

35. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets

Bozdag-Pehlivan S., Subasi B., VURAL İ., Unlu N., ÇAPAN Y.

Acta Poloniae Pharmaceutica - Drug Research , cilt.68, sa.3, ss.423-433, 2011 (SCI-Expanded)

36. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(ε-caprolactone) and chitosan nanoparticles

Cirpanli Y., Yerlikaya F., Ozturk K., Erdogar N., Launay M., Gegu C., et al.

Pharmazie , cilt.65, sa.12, ss.867-870, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

37. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles

ÖZTÜRK K., Caban S., Kozlu S., Kadayifci E., YERLİKAYA F., ÇAPAN Y.

Pharmazie , cilt.65, sa.9, ss.665-669, 2010 (SCI-Expanded)

38. LC-UV Determination of Melatonin from Chitosan Nanoparticles

Yerlikaya F., Aktas Y., ÇAPAN Y.

CHROMATOGRAPHIA , cilt.71, ss.967-970, 2010 (SCI-Expanded)

39. A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection

KARATAS H., AKTAS Y., GURSOY-OZDEMIR Y., BODUR E., YEMISCI M., CABAN S., et al.

Journal of Neuroscience , cilt.29, sa.44, ss.13761-13769, 2009 (SCI-Expanded)

40. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF TAMOXIFEN CITRATE USING NORMAL PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Yerlikaya F., Launay M., Gegu C., Leturgez T., BİLENSOY E., ÇALIŞ S., et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.183-184, 2009 (SCI-Expanded)

41. Microbiological and clinical comparison of chlorhexidine buccoadhesive tablet and chlorhexidine mouthrinse

AKTAŞ A., GIRAY B., ÇAPAN Y., MENEMENLIOGLU D., HAYRAN M., IKINCI G., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.19, sa.5, ss.353-357, 2009 (SCI-Expanded)

42. Preparation and evaluation of alpha-phenyl-n-tert-butyl nitrone (PBN)-encapsulated chitosan and PEGylated chitosan nanoparticles

Pinarbasli O., AKTAŞ Y., DALKARA T., Andrieux K., Alonso M., Fernandez-Megia E., et al.

Pharmazie , cilt.64, sa.7, ss.436-439, 2009 (SCI-Expanded)

43. Preparation and Characterization of Salmon Calcitonin-biotin Conjugates

ÇETİN M., Youn Y. S., ÇAPAN Y., Lee K. C.

AAPS PHARMSCITECH , cilt.9, sa.4, ss.1191-1197, 2008 (SCI-Expanded)

44. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles

Cetin M., AKTAŞ Y., VURAL İ., ÇAPAN Y., DOĞAN A., DUMAN M., et al.

Drug Delivery , cilt.14, sa.8, ss.525-529, 2007 (SCI-Expanded)

45. Stability of antimicrobial decapeptide (KSL) and its analogues for delivery in the oral cavity

Na D. H., Faraj J., Capan Y., Leung K. P., DeLuca P. P.

PHARMACEUTICAL RESEARCH , cilt.24, sa.8, ss.1544-1550, 2007 (SCI-Expanded)

46. Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system

Faraj J. A., Dorati R., Schoubben A., Worthen D., Selmin F., Capan Y., et al.

AAPS PHARMSCITECH , cilt.8, sa.1, 2007 (SCI-Expanded)

47. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres

YEMİŞCİ ÖZKAN M., PEHLİVAN S., Çetin M., Söylemezoglu F., ÇAPAN Y., DALKARA T., et al.

Neurosurgery , cilt.59, sa.6, ss.1296-1302, 2006 (SCI-Expanded)

48. Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain

KİLİC A. C., Capan Y., Vural I., Gursoy R. N., Dalkara T., CUİNE A., et al.

JOURNAL OF MICROENCAPSULATION , cilt.22, sa.6, ss.633-641, 2005 (SCI-Expanded)

49. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26

AKTAŞ Y., YEMİŞCİ ÖZKAN M., Andrieux K., Gursoy R., Alonso M., Fernandez-Megia E., et al.

BIOCONJUGATE CHEMISTRY , cilt.16, sa.6, ss.1503-1511, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

50. Chewing gum of antimicrobial decapeptide (KSL) as a sustained antiplaque agent: Preformulation study

Na D., Faraj J., ÇAPAN Y., Leung K., DeLuca P.

JOURNAL OF CONTROLLED RELEASE , cilt.107, sa.1, ss.122-130, 2005 (SCI-Expanded)

51. Preparation and characterization of bFGF and BSA-loaded microspheres

ÇETİN M., ÇAPAN Y., Vural I., Dogan A., Guc D., Hincal A., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.15, sa.5, ss.371-375, 2005 (SCI-Expanded)

52. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor

AKTAŞ Y., ANDRİEUX K., ALONSO M. J., CALVO P., Gursoy R. N., COUVREUR P., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.298, sa.2, ss.378-383, 2005 (SCI-Expanded)

53. Formulation and in vitro bioactivity of mitoxantrone-loaded biodegradable microspheres on rat glioma (RG2) cells

PEHLİVAN S., ÇAPAN Y., DALKARA T., DOĞAN A., Guc D., Hincal A., et al.

Journal of Drug Delivery Science and Technology , cilt.15, sa.3, ss.201-206, 2005 (SCI-Expanded)

54. In vitro cytotoxicity of mitoxantrone-incorporated albumin microspheres on acute promyelocytic leukaemia cells

Bozdag S., ÇAPAN Y., Vural I., Dalkara T., Dogan A., Guc D., et al.

JOURNAL OF MICROENCAPSULATION , cilt.21, sa.7, ss.751-760, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

55. Effect of polymorphism on in vitro in vivo properties of carbamazepine conventional tablets

Elqidra R., Unlu N., ÇAPAN Y., Sahin G., Dalkara T., Hincal A.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.14, sa.2, ss.147-153, 2004 (SCI-Expanded)

56. In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine

Ikinci G., ÇAPAN Y., ŞENEL S., Alaaddinoglu E., DALKARA T., Hincal A.

Pharmazie , cilt.55, sa.10, ss.762-765, 2000 (SCI-Expanded)

57. Stability of poly(L-lysine)-complexed plasmid DNA during mechanical stress and DNase I treatment

Capan Y., Woo B., Gebrekidan S., Ahmed S., DeLuca P.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.4, sa.4, ss.491-498, 1999 (SCI-Expanded)

58. Influence of formulation parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA

Capan Y., Woo B., Gebrekidan S., Ahmed S., DeLuca P.

JOURNAL OF CONTROLLED RELEASE , cilt.60, sa.2-3, ss.279-286, 1999 (SCI-Expanded)

59. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA

ÇAPAN Y., Woo B., Gebrekidan S., Ahmed S., DeLuca P.

PHARMACEUTICAL RESEARCH , cilt.16, sa.4, ss.509-513, 1999 (SCI-Expanded)

60. Formulation and in vitro in vivo investigation of carbamazepine controlled-release matrix tablets

Ikinci G., Capan Y., Senel S., Dalkara T., Hincal A.

PHARMAZIE , cilt.54, sa.2, ss.139-141, 1999 (SCI-Expanded)

61. Histological and bioadhesion studies on buccal bioadhesive tablets containing a penetration enhancer sodium glycodeoxycholate

Senel S., Capan Y., Sargon M. F., Giray C. B., Hincal A.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.170, sa.2, ss.239-245, 1998 (SCI-Expanded)

62. In vitro studies on enhancing effect of sodium glycocholate on transbuccal permeation of morphine hydrochloride

Senel S., Duchene D., Hincal A., Capan Y., Ponchel G.

JOURNAL OF CONTROLLED RELEASE , cilt.51, ss.107-113, 1998 (SCI-Expanded)

63. Enhancement of transbuccal permeation of morphine sulfate by sodium glycodeoxycholate in vitro

Senel S., Capan Y., Sargon M. F., Ikinci G., Solpan D., Guven O., et al.

JOURNAL OF CONTROLLED RELEASE , cilt.45, sa.2, ss.153-162, 1997 (SCI-Expanded)

64. Design and evaluation of sustained-release and buccal adhesive propranolol hydrochloride tablets

Taylan B., Capan Y., Guven O., Kes S., Hincal A.

JOURNAL OF CONTROLLED RELEASE , cilt.38, sa.1, ss.11-20, 1996 (SCI-Expanded)

65. FORMULATION AND IN-VITRO IN-VIVO EVALUATION OF BUCCOADHESIVE MORPHINE-SULFATE TABLETS

ANLAR S., ÇAPAN Y., GUVEN O., GOGUS A., DALKARA T., HINCAL A.

PHARMACEUTICAL RESEARCH , cilt.11, sa.2, ss.231-236, 1994 (SCI-Expanded)

66. FORMULATION, BIOAVAILABILITY, AND PHARMACOKINETICS OF SUSTAINED-RELEASE POTASSIUM-CHLORIDE TABLETS

ŞENEL S., ÇAPAN Y., DALKARA T., INANC N., HINCAL A.

PHARMACEUTICAL RESEARCH , cilt.8, sa.10, ss.1313-1317, 1991 (SCI-Expanded)

67. FORMULATION AND INVITRO-INVIVO EVALUATION OF SUSTAINED-RELEASE LITHIUM-CARBONATE TABLETS

CIFTCI K., ÇAPAN Y., OZTURK O., HINCAL A.

PHARMACEUTICAL RESEARCH , cilt.7, sa.4, ss.359-363, 1990 (SCI-Expanded)

68. INFLUENCE OF TECHNOLOGICAL FACTORS ON FORMULATION OF SUSTAINED-RELEASE TABLETS

ÇAPAN Y.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.15, sa.6-7, ss.927-956, 1989 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler 31

1. Silica nanoparticle synthesis by experimental design for drug and gene delivery applications

Ultav G., TONBUL H., ŞAHİN A., ÇAPAN Y.

Journal of Research in Pharmacy , cilt.27, sa.1, ss.12-22, 2023 (Scopus)

2. Brain-targeted nanoparticles to overcome the blood-brain barrier

SEKO I., ŞAHİN A., TONBUL H., ÇAPAN Y.

Journal of Pharmaceutical Technolgy , cilt.1, sa.1, ss.26-40, 2020 (Hakemli Dergi)

3. Development of paclitaxel and flurbiprofen co-loaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett-Burman design

Sahin A., Caban-Toktas S., Tonbul H., Yerlikaya F., AKTAŞ Y., ÇAPAN Y.

ISTANBUL JOURNAL OF PHARMACY , cilt.49, sa.3, ss.161-166, 2019 (ESCI) Sürdürülebilir Kalkınma

4. Beyine İlaç Tașınması: Truva Atı Teknolojisi

DOĞAN S., Toktaş S., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.34, sa.1, ss.1-16, 2014 (Scopus) Sürdürülebilir Kalkınma

5. Brain drug targeting Beyine İlaç Hedeflendirme Stratejileri

DOĞAN S., Çaban S., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.33, sa.2, ss.231-250, 2013 (Scopus)

6. Beyine İlaç Hedeflendirme Stratejileri

DOĞAN S. S., TOKTAŞ S., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , 2013 (Hakemli Dergi)

7. Formulation and In Vitro Evaluation of Paclitaxel Loaded Nanoparticles

Aygul G., YERLİKAYA F., CabanToktas S., Vural I., Capan Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.33, sa.1, ss.25-40, 2013 (Scopus)

8. Formulation and in vitro evaluation of paclitaxel loaded nanoparticles Paklitaksel yüklü nanopartiküllerin formülasyonu ve in vitro incelenmesi

Aygül G., Yerlikaya F., Caban S., VURAL İ., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.33, sa.1, ss.25-40, 2013 (Scopus)

9. Orally disintegrating tablets ii: In vitro and in vivo evaluations Aǧızda daǧılan tabletler ii: In vitro ve in vivo deǧerlendirilmeleri

Ölmez S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.31, sa.1, ss.59-70, 2011 (Scopus)

10. Orally disintegrating tablets i: Preparation technologies Aǧizda daǧilan tabletler i: Hazirlama teknolojileri

Ölmez S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.30, sa.2, ss.205-230, 2010 (Scopus)

11. Pharmaceutical quality by design: Quality by design approach and its elements Farmasötik tasarimla kalite: Tasarimla kalite yaklaşimi ve unsurlari

YÜCE M., ÇAPAN Y.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.39, sa.4, ss.369-390, 2010 (Scopus)

12. Etodolac loaded poly (lactide-co-glycolide) nanoparticles: Formulation and in vitro characterization Etodolak yüklü poli (Laktid-ko-glikolid) nanopartikülleri: Formülasyon ve i̇n vitro karakter

Çirpanli Y., Robineau C., ÇAPAN Y., ÇALIŞ S.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.29, sa.2, ss.105-114, 2009 (Scopus)

13. Desensitization to allopurinol in a patient with fixed drug eruption

Damadoglu E., Isik S. R., KARAKAYA G., ÇAPAN Y., KALYONCU A. F.

ASTIM ALLERJI IMMUNOLOJI , cilt.7, sa.3, ss.194-197, 2009 (ESCI)

14. Preparation and characterization of BSA-loaded alginate microspheres

ÇETİN M., VURAL İ., ÇAPAN Y., Hincal A. A.

Fabad Journal of Pharmaceutical Sciences , cilt.32, sa.3, ss.103-107, 2007 (Scopus)

15. Brai̇n drug targeti̇ng Beyne i̇laç hedeflendi̇ri̇lmesi̇

Çetin M., ÇAPAN Y.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.33, sa.4, ss.287-305, 2004 (Scopus)

16. Method Validation in Determination of Mitoxantrone by HPLC

Bozdaǧ S., ÇAPAN Y., VURAL İ., Hincal A. A.

Acta Pharmaceutica Turcica , cilt.46, sa.1, ss.43-47, 2004 (Scopus)

17. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone

ÇAPAN Y., Jiang G., Giovagnoli S., Na K., DeLuca P. P.

AAPS PharmSciTech , cilt.4, sa.2, 2003 (Scopus)

18. Mitoxantrone loaded poly(DL-lactide-co-glycolide) microspheres for treatment of brain tumors I. formulation and release characteristics

PEHLİVAN S., ÇAPAN Y., VURAL İ., Hincal A., DeLuca P.

Technology and Health Care , cilt.10, sa.3-4, ss.353-355, 2002 (Scopus)

19. Starch micropheres: Importance, preparation and applications Nisasta mikrokureleri: Onemi - Hazirlanisi - Uygulanmalari

Selek H., ÇAPAN Y., Kas H.

Fabad Journal of Pharmaceutical Sciences , cilt.24, sa.1, ss.31-42, 1999 (Scopus)

20. Formulation and in vitro/in vivo evaluation of buccal bioadhesive captopril tablets

Yaziksiz Işcan Y., ÇAPAN Y., ŞENEL S., ŞAHİN M. G., Kes S., Duchêne D., et al.

S.T.P. Pharma Sciences , cilt.8, sa.6, ss.357-363, 1998 (Scopus)

21. Formulation and comparative bioavailability of conventional and sustained release furosemide tablets

Farshi F., ÇAPAN Y., Kes S., Hincal A.

S.T.P. Pharma Pratiques , cilt.5, sa.5, ss.361-366, 1995 (Scopus)

22. Topographical dissolution characterization for sustained release furosemide tablets

Farshi F., ÇAPAN Y., Atilla Hincal A.

Acta Pharmaceutica Turcica , cilt.36, sa.4, ss.118-127, 1994 (Scopus)

23. Physico-chemical and bioadhesive properties of polyacrylamic acid polymers

Anlar S., ÇAPAN Y., Hincal A.

Pharmazie , cilt.48, sa.4, ss.285-287, 1993 (Scopus)

24. Formulation and efficacy of sustained-release theophylline tablets

ÇAPAN Y., Capan N., Kas H., Atikcan S., Baser Y., Hincal A.

S.T.P. Pharma Sciences , cilt.2, sa.2, ss.169-173, 1992 (Scopus)

25. Factors affecting the formulation of sustained release potassium chloride tablets

ŞENEL S., ÇAPAN Y., Hincal A.

Pharmazie , cilt.46, sa.11, ss.792-795, 1991 (Scopus)

26. Influence of filler excipients on the release rate of sustained release lithium carbonate tablets

ÇAPAN Y., Ciftci K., Atilla Hincal A.

European Journal of Pharmaceutics and Biopharmaceutics , cilt.37, sa.1, ss.14-18, 1991 (Scopus)

27. Evaluation of sustained release lithium carbonate tablets from urine

Ciftci K., ÇAPAN Y., Hincal A.

S.T.P. Pharma Sciences , cilt.1, sa.4, ss.272-275, 1991 (Scopus)

28. Sustained release isoniazid tablets II. In vivo evaluation

ÇAPAN Y., Kas S., ÖNER L., Bulut-Oner F., Hincal A.

Sciences Techniques et Pratiques Pharmaceutiques , cilt.6, sa.7, ss.460-463, 1990 (Scopus)

29. Formulation and in vitro-in vivo evaluations on sustained release acetylsalicylic acid tablets

ÇAPAN Y., ŞENEL S., ÇALIŞ S., Takka S., Hincal A.

Pharmazeutische Industrie , cilt.51, sa.4, ss.443-448, 1989 (Scopus)

30. Sustained release isoniazid tablets I-formulation and in vitro evaluation

Bulut-Oner F., ÇAPAN Y., Kas S., ÖNER L., Hincal A.

Farmaco , cilt.44, sa.7-8, ss.739-752, 1989 (Scopus)

31. Formulation studies of the wetting solutions for hard contact lenses. 1. Microbiological studies Sert kontakt lens islatma çözeltileri üzerinde formülasyon çalişmalari. 1. Mikrobiyolojik çalişmalar.

Unlü N., ÇAPAN Y., Yuluǧ N.

Mikrobiyoloji Bulteni , cilt.15, sa.3-4, ss.179-187, 1981 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 44

1. KOZMETİK ENDÜSTRİSİ

Gür B., Çapan Y., Büyükekmekci İ., Deveci Z., Demirkapı E. N., Şenol B., et al.

Pharmacopolium ile 21. Yüzyılda Eczacılık, Ankara, Türkiye, 10 - 12 Mayıs 2022, ss.8, (Özet Bildiri)

2. KANSER TEDAVİSİNDE NANOPARTİKÜLLER

Gür B., Çapan Y., Akifbey M., Deveci Z., Büyükekmekci İ., Çolak H.

Pharmacopolium ile 21. Yüzyılda Eczacılık, Ankara, Türkiye, 10 - 12 Mayıs 2022, ss.7, (Özet Bildiri) Sürdürülebilir Kalkınma

3. NANOTEKNOLOJİ İLE BEYİN HEDEFLİ SİSTEMLER

Gür B., Çapan Y., Kılınçkaya D., Deveci E., Şenol B., Demirkapı E. N.

Pharmacopolium İle 21. Yüzyılda Eczacılık, Ankara, Türkiye, 10 - 12 Mayıs 2022, ss.7, (Özet Bildiri)

4. Lokman Hekim Üniversitesi Eczacılık Fakültesi öğrenci asistanlığı uygulaması

Gümüşel B., Özden M. S., Onur F., Çapan Y., Gümüşel B., Yıldız S., et al.

III. Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, Ankara, Türkiye, 17 - 19 Kasım 2021, ss.37, (Özet Bildiri)

5. Lokman Hekim Üniversitesi Eczacılık Fakültesi "Eczacılığa Giriş ve Terminoloji" Dersinin Öğrencilerin Mesleki Farkındalık Düzeylerine Katkısı

Özden M. S., Çapan Y., Gümüşel B., Konuklugil B., Erikçi A., Yerlikaya F., et al.

III. Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, Ankara, Türkiye, 17 - 19 Kasım 2021, ss.73, (Özet Bildiri)

6. LOKMAN HEKİM ÜNİVERSİTESİ ECZACILIK FAKÜLTESİNDE PANDEMİ KOŞULLARINDA EĞİTİM UYGULAMALARI

Çapan Y.

III. ECZACILIK EĞİTİMİ VE AKREDİTASYON KONGRESİ, 17 - 19 Kasım 2021, ss.52, (Özet Bildiri)

7. LOKMAN HEKİM ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ “ECZACILIĞA GİRİŞ ve TERMİNOLOJİ” DERSİNİN ÖĞRENCİLERİN MESLEKİ FARKINDALIK DÜZEYLERİNE KATKISI

Çapan Y.

III. Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, İstanbul, Türkiye, 17 - 19 Kasım 2021, ss.73, (Özet Bildiri)

8. Folic Acid Conjugated Mesoporous Silica Nanoparticles For Enhanced Therapeutic Efficacy of Doxorubicin İn Breast Cancer

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., TAVUKCUOĞLU E., AKTAŞ Y., et al.

8th BBBB Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, cilt.1, ss.184-186, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

9. PREPERATION, CHARACTERIZATION, CYTOTOXICITY EVALUATIONS OFFOLIC ACID CONJUGATED MESOPOROUS SILICA NANOPARTICLES

TONBUL H., ultav g., akbas s., sahin a., tavukcuoglu e., AKTAŞ Y., et al.

19th InternationalPharmaceutical Technology Symposium-IPTS 2018, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

10. IN VITRO EVALUATION OF PACLITAXEL LOADED MESOPOROUS SILICA NANOPARTICLES

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., AKTAŞ Y., ÇAPAN Y.

EUFEPS Annual Meeting 2018, 24 - 26 Mayıs 2018, (Özet Bildiri)

11. DEVELOPMET AND EVALUATION OF SILICA NANOPARTICLES USING A QUALITY BY DESIGN APPROACH

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., AKTAŞ Y., ÇAPAN Y.

EUFEPS Annual Meeting 2018, 24 - 26 Mayıs 2018, (Özet Bildiri)

12. Synthesis and Characterization of Silica Nanoparticles: Obtaining nanoparticles smaller than 100 nm

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., KAYNAK M. S., AKTAŞ Y., et al.

2nd International Gazi Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)

13. Transferrine hedeflendirilmiş paklitaksel yüklü PLGA nanopartiküllerinin meme kanserindeki etkinliği

TONBUL H., ŞAHİN A., ÖZTÜRK N., VURAL İ., KAYNAK M. S., ÇAPAN Y.

1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu (ANES), Türkiye, 1 Haziran - 02 Ocak 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Comparing Intracellular Delivery of PLGA and Chitosan Nanoparticles Lessons and Challenges

ŞAHİN A., Yerlikaya F., AKTAŞ Y., ESENDAĞLI G., ÇAPAN Y.

GPEN 2016, 9 - 12 Kasım 2016

15. Drug Delivery with Targeted Nanoparticles: in Vitro and in Vivo Evaluation Methods.

ÇAPAN Y.

17th International Pharmaceutical Technology Symposium, 18 - 21 Ekim 2016

16. Co Encapsulation Studies of Doxorubicin and Celecoxib in PLGA Nanoparticles

Kozlu S., ŞAHİN A., Sevda Ş., Yerlikaya F., ÇAPAN Y.

18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 Eylül 2916 - 21 Eylül 2016

17. Development and in vitro evaluation of transferrin targeted PLGA nanoparticle

TONBUL H., ŞAHİN A., KAYNAK M. S., ÇAPAN Y.

18th International Pharmaceutical Technology Symposium-IPTS 2016, 19 - 21 Eylül 2016

18. Intracellular delivery and intraperıtoneal retention of different sized PLGA nanoparticles prepared by nanoprecipitation method

ŞAHİN A., ESENDAĞLI G., Fırat Y., Serhat K., Yöyen Ermis D., Horzum U., et al.

18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 - 21 Eylül 2016

19. Brain drug delivery

ÇAPAN Y.

International Conference on Advances in the Area of Bioequivalance, Pharmaceutical Technology Symposium, 14 Kasım 2015

20. Particle Size Optimization of Ibuprofen Loaded PLGA Nanoparticles Using Box Behnken Design

ŞAHİN A., Çaban S., AKTAŞ Y., ÇAPAN Y.

AAPS 2015 Annual Meeting, 25 - 29 Ekim 2015

21. Effects of Combined Surfactants in the Formulation of Docetaxel Loaded PLGA Nanoparticles

Abdykerim Kyzy G., Çaban S., ŞAHİN A., ÇAPAN Y.

AAPS Annual Meeting 2015, 25 - 29 Ekim 2015

22. Determination of Critical Parameters of Paclitaxel and Flurbiprofen Co Loaded PLGA Nanoparticles Prepared By Nanoprecipitation

ŞAHİN A., Çaban S., Abdykerim Kyzy G., Yerlikaya F., AKTAŞ Y., ÇAPAN Y.

AAPS Annual Meeting 2015, 25 - 29 Ekim 2015

23. Nanoscale drug delivery systems and the blood brain barrier

ÇAPAN Y.

International Multidisciplinary Symposium on Drug Research & Development 2015, 15 - 17 Ekim 2015, (Özet Bildiri)

24. Nanoscale drug delivery systems and the blood-brain barrier

ÇAPAN Y.

17th International Pharmaceutical Technology Symposium, 8 - 10 Eylül 2014

25. Nanoparticular Drug Delivery Systems Pharmaceutical Applications

ÇAPAN Y.

IAEA Regional Training Course on ˝Radiation Synthesis and Characterization of Nanostructures, 8 - 12 Kasım 2010

26. The importance of particle size analysis: Its role in pharmaceutical development

ÇAPAN Y.

United States Pharmacopeia and Ekin Kimya 4th Science Standards Symposium, 15 Ekim 2010

27. Brain Drug Targetting

ÇAPAN Y.

15th Internetional Pharmaceutical Technology Symposium, 13 - 15 Ekim 2010

28. Brain Drug Targeting

ÇAPAN Y.

6th International Biomedical Science and Technology Symposium, 28 Eylül - 02 Ekim 2010

29. Brain Drug Targeting IMPPS-3

ÇAPAN Y.

Third International Meeting On Pharmacy Pharmaceutical Sciences, 9 - 12 Haziran 2010

30. Evaluation of the products with the same formula on the point of pharmaceutical technolgy

ÇAPAN Y.

Turkish Society of Hematology Updating on Hematological Oncology Meeting, 6 - 09 Mayıs 2009

31. Bioavailability Bioequivalance

ÇAPAN Y.

BioInternational 2008, 22 - 24 Ekim 2008

32. Perspectives in drug release from micro- and nanoparticulate drug delivery systems

ÇAPAN Y.

14th Internetional Pharmaceutical Technology Symposium, 6 - 10 Eylül 2008

33. Blood Brain Barrier Delivery with Molecular Trojan Horses

ÇAPAN Y.

14th Internetional Pharmaceutical Technology Symposium, 6 - 10 Eylül 2008

34. Bioavailability and Bioequivalance

ÇAPAN Y.

34. National Haematology Congress, 10 - 11 Ağustos 2008

35. Technological Factors Influencing BA / BE

ÇAPAN Y.

FATUM Symposium on Bioavailability / Bioequivalance and Regulatory Issues, 17 - 18 Mart 2008

36. Recent Advances in Brain Drug Delivery

ÇAPAN Y.

16th International Symposium on Microencapsulation, 09 Eylül 2007

37. BE practice and issues in Turkey

ÇAPAN Y.

Biointernational 2005, 24 - 25 Ekim 2005

38. An overview of dissolution and bioequivalence

ÇAPAN Y.

Hands-On-Dissolution Workshop, 10 - 11 Ekim 2005

39. Nanoparticle technology its Pharmaceutical Applications

ÇAPAN Y.

FIP Meeting, 01 Ocak 2005

40. Preparation and Characterization of Basic Fibroblast Growth Factor (bFGF)-Loaded Microparticulate Drug Delivery Systems,

ÇETİN M., ÇAPAN Y., VURAL İ., GÜRSOY R. N., DALKARA T., Cuine A., et al.

2004 AAPS Annual Meeting and Exposition, Maryland, Amerika Birleşik Devletleri, 31 Ekim 2004, (Tam Metin Bildiri)

44. Preparation and Characterization of Poly (D,L-lactide-co-glycolide) Microspheres For Controlled Release of Poly (L-Lysine) Complexed Plasmid DNA

ÇAPAN Y.

8th Biomedical Science and Technology Symposium, 5 - 08 Eylül 2000

Metrikler

Yayın

156

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

1664

H-İndeks (WoS)

Atıf (Scopus)

2492

H-İndeks (Scopus)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)